Q1 2022

Filed May 6, 2022 · 10-Q · 36 days after period end · 0001493152-22-012380

Q1 2022 · 10-Q

Revenue—

Net Income

-$1.05M

N/M vs Q1 2021

EPS, diluted—

Operating Income-$545,711N/M

Operating Cash Flow-$479,319N/M

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2020	Q1 2019
Revenue	—	—	—	$0.00
Net Income	-$1.05M	-$940.66K	-$3.05M	-$477.75K
EPS Diluted	—	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR